AstraZeneca-Oxford vaccine safe, Indian trials progressing smoothly: Serum Institute

SII is conducting clinical trials of AstraZeneca-Oxford's COVID-19 vaccine candidate in India

AstraZeneca-Oxford vaccine safe, Indian trials progressing smoothly: Serum Institute

A statement describing the error came days after the company and the university described the shots as "highly effective" and made no mention of why some study participants did not receive as much vaccine in the first of two shots as expected. — Reuters

New Delhi, November 26

Vaccine major Serum Institute of India on Thursday said the COVID-19 vaccine developed by AstraZeneca and Oxford University is safe and effective, and the Indian trials are progressing smoothly with strict adherence to all protocols.

The comments came after AstraZeneca and Oxford University acknowledged a manufacturing error that is raising questions about preliminary results of their experimental COVID-19 vaccine.

A statement describing the error came days after the company and the university described the shots as "highly effective" and made no mention of why some study participants did not receive as much vaccine in the first of two shots as expected.

Asking people to be patient and not panic, the Serum Institute of India (SII) said in a statement, "The AstraZeneca-Oxford vaccine is safe and effective. Even the lowest efficacy results are at 60-70%, making it a viable vaccine against the virus."

That said, varied age groups with different dosage forms will result in slight variations and efficacy. "We must be patient and not panic," it added.

SII is conducting clinical trials of AstraZeneca-Oxford's COVID-19 vaccine candidate in India.

"The Indian trials are running smoothly with strict adherence to all the necessary processes and protocols. So far, there are no concerns. However, we are going through the data that is available and will make further statement, if needed," SII said.

Earlier this week, AstraZeneca said an interim analysis of clinical trials of its COVID-19 vaccine in the UK and Brazil showed that it was 70 per cent effective on average, becoming the third drugmaker to announce promising results to contain the deadly virus.

The company had also said that the vaccine, developed with the University of Oxford, showed 90 per cent efficacy in one dosing regimen when the vaccine was given as a half dose, followed by a full dose at least a month later, while another dosing regimen showed 62 per cent efficacy when given as two full doses at least one month apart.

"The combined analysis from both dosing regimens resulted in an average efficacy of 70 per cent," it had said. PTI 

Top Stories

How extremist elements hijacked farmers' rally and Deep Sidhu’s role in chaos

How extremist elements hijacked farmers' rally and Deep Sidhu’s role in chaos

A month ago, one of the farmer leaders had termed Deep Sidhu...

MHA orders additional forces in Delhi as farmers lay siege to the Red Fort, break Tikri Border barricades

MHA orders additional forces in Delhi as farmers lay siege to the Red Fort, break Tikri Border barricades

Tension in and around Delhi after thousands of farmers storm...

Tractor parade becomes violent; farmers enter Red Fort, hoist flag

Tractor parade becomes violent; farmers enter Red Fort, hoist flag

Farmers run riot on Delhi roads, defy barricades to reach Re...

Samyukta Kisan Morcha calls off tractor march after Delhi violence

Samyukta Kisan Morcha calls off tractor march after Delhi violence

Says peaceful protests will continue

Once a small breakaway faction, Kisan Mazdoor Sangharsh Committee now at centre of Delhi struggle

Once a small breakaway faction, Kisan Mazdoor Sangharsh Committee now at centre of Delhi struggle

Organisation formed in 2007 now has presence in seven or eig...

Cities

View All